(All fields required)
Please enter a valid email.
Please enter your name.
Ours is a multicultural laboratory of students, postdoctoral fellows and staff from across the globe, in which we develop productive scientific creativity. With a focus on career progression, we provide a rich scientific environment surrounded by remarkable core support and institutional resources.
Max Bergman received his B.S. in Microbiology from The Ohio State University in 2012. He is currently working as a laboratory technician and seeking to further his research experience while preparing for advanced studies in medical sciences.
Mike Burhans holds a Masters in Biomedical Science. He has worked at Cincinnati Children’s Hospital Medical Center for much longer than anyone else in the lab.
Allison Dixon received her B.S. in 2012 from Bellarmine University in Biochemistry and Molecular Biology. Allison is currently pursuing a Ph.D. in the Department of Pharmacology and Cell Biophysics at the University of Cincinnati Medical Center.
Fadia A. Kamal received her Ph.D. in Cell Physiology at Niigata University, Japan 2010, in addition to her PharmD from Beirut Arab University. Fadia currently studies the therapeutic potential of small molecule G-protein inhibitors in
Michael Petrany is an undergraduate student at Xavier University, Class of 2014, pursuing degrees in biology and philosophy with minors in chemistry and German. He joined the Blaxall lab in January 2013 and is working in Summer 2013 as a SURF student sponsored by the American Heart Association.
Rashmi Ram has a clinical cardiovascular surgery background as a Physician Assistant and a PhD in Cellular and Molecular Biology. Her current research focuses on the role of mammalian enabled (Mena), a critical regulator of actin dynamics in cardiac structure, function and conduction.
Emily Schulz received her Ph.D. in the Department of Molecular Genetics, Biochemistry and Microbiology at the University of Cincinnati Medical Center in 2012. She is currently studying the therapeutic potential of inhibiting dual-specificity kinases in pathological cardiac intercellular communication.
Joshua Travers received his B.S. in Biotechnology from the Rochester Institute of Technology in 2011. He is currently pursuing a Ph.D. in Pharmacology at the University of Cincinnati where he is investigating the role of small molecule Gβγ inhibition in cardiac fibroblasts, fibrosis and remodeling.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center